中文

正海生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-18
ItemAmountY/Y
Revenue¥0.08B-16.8%
Gross profit¥0.07B
Operating income¥0.02B
Net income¥0.01B-44.6%
Gross margin82.6%Net margin 18.2%
Revenue Q/Q-8.4%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.01B17.4%
R&D¥0.01B12.8%
SG&A¥0.04B50.5%
Tax & other¥0.00B3.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

世纪天鸿晶瑞电材民德电子弘信电子延江股份中孚信息江苏雷利科锐国际科蓝软件鹏鹞环保飞鹿股份江丰电子

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies